$Conduit Pharmaceuticals (CDT.US)$Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders GlobeNewswire· 5 mins ago Approval of composition of matter patent in key jurisdiction underscores the Company's commitment to maximize future out-licensing value
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Teddy123 : Like finally it's moving!
Trytosaveabit OP Teddy123 : Yup yup!
NoNo444 : not much movement? Max .4?
Trytosaveabit OP NoNo444 : Huh? Pretty big float! And it’s move over 100% so far! That a big move to me! Hehehe
Teddy123 : Any reference numbers to share pls @Trytosaveabit![stuck_out_tongue_winking_eye 😜](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f61c.png)
Trytosaveabit OP Teddy123 : Sorry I don’t! Not for this!
Teddy123 : Hehe no prob. Am just glad it's finally rising after mths!